DiviDrip · HBIO

HBIO — Harvard Bioscience, Inc.

HBIO is Harvard Bioscience, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $8.00. Market cap: $37M. Capital Quality Rank: 10/100 — Systemic risk.

Stock snapshot

Price$8.00
Market cap$37M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)10 / 100 · Systemic risk
ROIC (TTM)-93.6%
Revenue CAGR (3y)-8.6%
Shareholder buyback yield-1.92%
Altman Z-score zoneDistress

About HBIO

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Listed2000Employees339HQHolliston, MASectorHealthcareWebsiteharvardbioscience.com

Related non-dividend companies

Other non-dividend stocks investors research alongside HBIO. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is HBIO's current stock price?

HBIO (Harvard Bioscience, Inc.) is currently trading at $8.00.

Does HBIO pay a dividend?

HBIO (Harvard Bioscience, Inc.) does not currently pay a regular dividend.

What is HBIO's Capital Quality Rank?

HBIO has a Capital Quality Rank of 10/100 — Systemic risk. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track HBIO in DiviDrip

Add HBIO to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow